This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Kane: In talking ...
The new data were showcased in one of ten schizophrenia-related posters presented by Medincell’s partner, Teva, at the 2025 Psych Congress, held from September 17 to 21 in San Diego, California ...
Long-acting injections given once every two months can prevent HIV at least as well as daily pills for gay and bisexual men and transgender women, according to interim study results released May 18 by ...
Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study by researchers at UC San Francisco has found. The strategy could also help stop the spread ...
This educational resource was sponsored by Johnson & Johnson. In this educational resource, experts from a pharmacy and hospital provide an overview of their respective long-acting injectable ...
In a clinical trial led by Aadia Rana, M.D., professor in the UAB Division of Infectious Diseases, findings show that long-acting, injectable antiretroviral therapy (ART) is more effective in ...
Initial data from the CLARITY study are first to compare acceptability and tolerability of single-dose cabotegravir (CAB) and lenacapavir (LEN) long-acting injections, in 63 HIV-negative adults ...
A treatment option that serves as an alternative to daily pills for mental health patients is becoming more and more popular. "I have definitely found my patients have asked for long-acting ...
The federal Food and Drug Administration has approved Apretude (extended-release cabotegravir), the first long-acting injectable option for HIV prevention. The shots, which are administered by a ...
This educational activity is supported by an independent educational grant from ViiV Healthcare. ViiV Healthcare was not involved in the development of content or selection of faculty for this ...
CVS is now covering long-acting injectable PrEP, representing a shift from last year when the pharmacy giant announced it was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback